The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Naturally Occurring Antibodies May Lead to New RA Therapies

Naturally Occurring Antibodies May Lead to New RA Therapies

December 1, 2010 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body.1 These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.

You Might Also Like
  • Research on IL-17 Cytokine May Lead to Novel Therapies for RA
  • Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction
  • Research Tracks Possible Benefit of Src-like Adaptor Protein
Explore This Issue
December 2010
Also By This Author
  • HIPAA Security Standards: What Rheumatologists Need to Know

The lead researcher of this ongoing work, Gregg J. Silverman, MD, of the University of California, San Diego School of Medicine, is a recipient of an ACR Research and Education Foundation (REF) Within Our Reach: Finding a Cure for Rheumatoid Arthritis research grant.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Gregg J. Silverman, MDWe’re trying to bottle a little bit of Mother Nature that will help get people back into balance.

—Gregg J. Silverman, MD

“Following different clues, we have discovered that the human immune system contains naturally occurring antibodies that have the ability to down-regulate inflammatory response from the more primitive innate immune system,” Dr. Silverman says. “What this means is that this ancient innate part of our immune system is meant to respond dramatically, quickly, and vigorously to any kind of foreign threat. These are meant to attack infectious agents. The problem is when that same response becomes dysregulated and over-exuberant, it becomes one of the most destructive aspects of autoimmune diseases, including rheumatoid arthritis,” he notes.

“The good news,” continues Dr. Silverman, “is that these antibodies also can suppress inflammation. We think we can use these antibodies to provide a targeted approach to suppress inflammation by pathways that appear to be very similar to those of corticosteroids, which are the most commonly used immunosuppressive agents for rheumatic and inflammatory diseases.”

But unlike corticosteroids, potential therapies using these natural antibodies would be much less likely to have serious side effects.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“It’s absolutely unexpected that we’ve been able to show very powerful properties equivalent to the strongest doses of corticosteroids while using very low levels of these natural occurring antibodies,” Dr. Silverman says. “We’re trying to bottle a little bit of Mother Nature that will help get people back into balance.”

Support Research

To make a pledge or one-time donation to the REF for the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign, visit www.rheumatology.org/REF. For more information about the Within Our Reach campaign and to read about the grant projects, visit www.WithinOurReach.info.

Dr. Silverman says that thus far this research has been focused primarily in mice, but the investigators have found remarkable parallels between the mouse immune system and the human immune system.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, From the College, Research Reviews, Rheumatoid Arthritis Tagged With: Antibodies, Basic research, RA, REF News, Rheumatoid arthritisIssue: December 2010

You Might Also Like:
  • Research on IL-17 Cytokine May Lead to Novel Therapies for RA
  • Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction
  • Research Tracks Possible Benefit of Src-like Adaptor Protein
  • Major Grant Funding for Collaborative RA Projects

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.